What i have Learned from French Psychiatry

10.4103/TPSY.TPSY_13_23

Naotaka Shinfuku

French psychiatry ； chlorpromazine ； community mental health service ； World Psychiatric Association ； Asian Federation of Psychiatric Associations

台灣精神醫學

37卷2期（2023 / 06 / 01）

61 - 69

英文

Background: I studied psychiatry in France from 1971 to 1974 as a French government-scholarship student. I became familiar with a history of French psychiatry, the development of chlorpromazine, new movement of community psychiatry away from hospital-centered psychiatry. What I learned in France became the background for my clinical psychiatric practice after returning to Japan. My experience in France was also useful when I later worked at the World Health Organization (WHO), where I remained involved in shaping national policies concerning mental health in Asian countries. The lessons I have learned in France are innumerable. French psychiatry has made a monumental contributions to the world psychiatry. But these facts are not well-known to Asian countries. Methods: Based on my experiences, I would like to introduce several achievements made by French psychiatry. Results: During my studying psychiatry in France, 1971-1974, I learned France being one of birthplaces of psychiatry, witnessed the birth of the World Psychiatric Association (WPA), heard of discoveries of psychotropic drugs, experienced the academic activities at l'Hôpital Sainte Anne, as well as exposed myself to a community mental health center and deinstitutionalization to learn a different way in taking care chronic patients with schizophrenia. Conclusion: My valuable studying experiences in France have had huge influences in my later psychiatric career, such as helping the development of mental health policy in countries of the Western Pacific Region of WHO, doing the research on the use of psychotropic drugs in Asia (REAP), involving in the WPA, and founding the Asian Federation of Psychiatric Associations.

1. Shinfuku, N(2014).Research on Asian Prescription Patterns (REAP): focusing on data from Japan.Taiwan J Psychiatry,28,71-85.
   連結：
2. Shinfuku, N(2016).Japanese culture, social events, and mental health laws: my personal observations.Taiwan J Psychiatry Taipei)),30,146-157.
   連結：
3. Shinfuku, N(2012).What is happening in the mental health system in Japan.Some observations. Taiwan J Psychiatry,26,70-76.
   連結：
4. Shinfuku, N(2011).Disaster psychiatry: lessons learned from the Great Awaji Earthquake.Taiwan J Psychiatry,23,3-12.
   連結：
5. Shinfuku, N(2019).A history of mental health care in Japan; international perspectives.Taiwan J Psychiatry (Taipei),33,179-191.
   連結：
6. Barton, R(1966).Institutional Neurosis.Bristol, United Kingdom:John Wright and Sons.
7. Chong, MY,Tan, CH,Fujii, S(2004).Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.Psychiatry Clin Neurosci,58,61-67.
8. Clark, D(1968).,Manila:WHO Regional Office for the Western Pacific.
9. Goffman, E(1961).Ancho Books.New York:Doubleday.
10. Hsu, ST(2023).In memorarium: Cheng-Chung Chen, M.D., Ph.D, 1957-2023.Taiwan J Psychiatry,37,5-7.
11. Kokai, M,Fujii, S,Shinfuku, N(2004).Natural disaster and mental health in Asia.Psychiatry Clin Neurosci,58,110-116.
12. Lin, TY(1982).,Manila, Philippines:World Health Organization Western Pacific Regional Office.
13. Lin, TY(1982).,Manila, Philippines:World Health Organization Western Pacific Regional Office.
14. López-Muñoz, F,Alamo, C,Cuenca, E(2005).History of the discovery and clinical introduction of chlorpromazine.Ann Clin Psychiatry,17,113-135.
15. Martin, DV(1955).Institutionalisation.Lancet,269,1188-1190.
16. Moussaoui, D(2002).A Biography of Jean Delay, the First President of the World Psychiatric Association: A History of the World Psychiatric Association.London, United Kingdom:Excerpta Medica, An Adelphi Group Company.
17. Omidi, CJ,Shen, WW(1995).Book Review on the American Psychiatric Press Textbook of Psychopharmacology.JAMA,1995,1886-1887.
18. Semelaigne R: Les Grands Aliéniste Français (The great French Psychiatrists). Volume 1 Philippe Pinel, Esquirol, Ferrus, Jean-Pierre Falret, Félix Voisin, Georget. Paris: Steinheil G, 1894, and re-printed by Paris: J.B. Bailliere and Son, 1930.
19. Shen, WW(1999).A history of antipsychotic drug development.Compr Psychiatry,40,407-414.
20. Shen, WW,Giesler, MC(1998).The discoverers of the therapeutic effect of chlorpromazine in psychiatry: qui étaient les vrais premiers praticiens?.Can J Psychiatry,43,423-424.
21. Shinfuku, N(1999).To be a victim and a survivor of the great Hanshin-Awaji Earthquake.J Psychosom Res,46,541-548.
22. Shinfuku, N(2022).Analysis of the trends of polypharmacy and high-dose prescriptions in Japan.Asia Pac Psychiatry,14,e12488.
23. Shinfuku, N(2022).Current national psychiatric societies of the AFPA and executive board members.Bulletin of the AFPA,9,17-18.
24. Tan, CH(2000).New challenges in psychopharmacology.Singapore Med J,41,3-4.
25. Udomratn, P,Shinfuku, N(2013).Asian federation of psychiatric associations and the 2013 world congress of Asian psychiatry.Taiwan J Psychiatry,27,99-100.
26. Wing, JK,Brown, GW(1970).Institutionalism and Schizophrenia: A Comparative Study of Three Mental Hospitals 1960-1968.London:Cambridge University Press.
27. World Health Organization Expert Committee on Mental Health(1975).WHO Technical Report SerieWHO Technical Report Serie,Geneva, Switzerland:World Health Organization.
28. World Health Organization Study Group(1984).WHO Technical Report SeriesWHO Technical Report Series,Geneva, Switzerland:World Health Organization.
29. Yang, SY,Chen, LY,Najoan, E(2018).Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: the REAP-AP4 study.Psychiatry Clin Neurosci,72,572-579.